Passage BIO PASG
NASDAQ PASG
$3.37 -0.14 (-3.99%)
As of: Oct 23, 2026 · 3:51 PM EDT

Passage BIO (PASG) Cash & Current Investments (2019 - 2026)

Updated

Passage BIO's Cash & Current Investments was $24.2 million in Q2 2026, down 58.0% from $57.63 million a year earlier and down 27.4% from the prior quarter.

Analysis

Passage BIO (PASG) Cash & Current Investments (2019 - 2026) Analysis & Trends

At the end of FY2025, Cash & Current Investments at Passage BIO came in at $46.3 million, down 39.7% from FY2024.

  • Cash & Current Investments has now declined for four consecutive years, with a five-year compound annual growth rate of -31.4% (FY2020 to FY2025).
  • In earlier years, Cash & Current Investments was $76.76 million in FY2024 (-32.8%), $114.29 million in FY2023 (-39.7%), $189.61 million in FY2022 (-40.0%) and $315.77 million in FY2021 (+3.6%).
  • The Q2 2026 figure marks the lowest quarterly Cash & Current Investments in data going back to Q4 2019.
  • Compared with a year earlier, Cash & Current Investments has declined for 18 straight quarters, with an average decline of 41.1% over the last eight quarters.
  • The best year-over-year quarter for Cash & Current Investments over five years was Q3 2021 (growth of 5.6%); the worst was Q2 2026 (a decline of 58.0%).
  • Per Business Quant data, PASG's Cash & Current Investments in the three quarters before Q2 2026 was $33.34 million (Q1 2026), $46.3 million (Q4 2025) and $52.77 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 17.23 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 6.57 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 11.70 Bn
10 Passage BIO 10.81 Mn -145.80 Mn - 24.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 24.20 Mn
Mar 31, 2026 33.34 Mn
Dec 31, 2025 46.30 Mn
Sep 30, 2025 52.77 Mn
Jun 30, 2025 57.63 Mn
Mar 31, 2025 63.36 Mn
Dec 31, 2024 76.76 Mn
Sep 30, 2024 84.83 Mn
Jun 30, 2024 91.77 Mn
Mar 31, 2024 104.53 Mn
Dec 31, 2023 114.29 Mn
Sep 30, 2023 132.78 Mn
Jun 30, 2023 151.48 Mn
Mar 31, 2023 167.77 Mn
Dec 31, 2022 189.61 Mn
Sep 30, 2022 213.76 Mn
Jun 30, 2022 239.25 Mn
Mar 31, 2022 267.09 Mn
Dec 31, 2021 315.77 Mn
Sep 30, 2021 354.40 Mn
API Access

Passage BIO Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=PASG&period=max&api_key=YOUR_API_KEY